GenomOncology
About GenomOncology
GenomOncology is a healthcare AI company that provides a precision oncology platform designed to transform complex and fragmented oncology data into actionable intelligence. Their solutions aim to improve cancer care by streamlining workflows for molecular pathologists, oncologists, clinical trial professionals, bioinformaticians, and clinical researchers. The company’s platform offers tools for molecular pathology reporting, clinical trial optimization, and data enablement, leveraging AI, natural language processing (NLP), and a comprehensive knowledge base.
For physicians, GenomOncology’s platform delivers transparent, explainable AI that generates real-time, auto-generated data interpretations at the point of care. This includes integrating all assay and lab data into a single report to increase operational efficiency. The platform also automates and customizes patient treatment with clinical trial matching, helping to accelerate enrollment and expand access to relevant studies. Furthermore, GenomOncology’s solutions seamlessly integrate with existing LIS, LIMS, and EHR systems for automated, bidirectional data exchange, ensuring that oncologists have access to comprehensive patient information for informed decision-making.
The company’s offerings address the growing complexity of precision oncology, where a vast number of FDA indications and active clinical trials can make identifying the “next-best decision” challenging. GenomOncology’s platform is built to unify data, workflows, and insights across cancer care, serving as an embedded intelligence layer within oncology ecosystems. This enables clinicians, labs, and researchers to act faster and with greater clarity, ultimately redefining how institutions deliver personalized care and advancing translational research.
Focus Areas
Business Intelligence
| Key Investors | Relevance Ventures, Next Sparc Growth Partners, TriStar Health Partners, JumpStart, Zapis Capital Group, Tri-Star Technology |
| Partnerships | Chronetyx Laboratories, OHSU Knight Diagnostics Lab, WeTrials, Glioblastoma Foundation, Pillar Biosciences, Precipio, Genomenon, Belay Diagnostics, Duke Cancer Institute |
| Acquisitions | unknown |
| Technology | cloud-native or on-premise deployment, AI-enabled Precision Oncology Platform (POP), augmented intelligence stack, AI/NLP-powered platform (igniteIQ), knowledge graph, symbolic AI, large language models (LLMs), natural language processing (NLP) |
| FDA Clearances | unknown cleared products (estimated) |
What Physicians Need to Know
For physicians, GenomOncology's solutions streamline complex genomic data into actionable insights, enabling faster, more confident, and scalable clinical decisions. The platform provides real-time, biomarker-specific clinical trial matching, integrating directly into existing workflows to reduce administrative burden and accelerate patient enrollment. The Pathology Workbench simplifies NGS reporting, offering comprehensive variant analysis and customizable reports that can be delivered directly to the EHR. The transparent and explainable AI delivers real-time, auto-generated data interpretations for every case, fostering trust and clarity in decision-making. Furthermore, the integration of prior treatment eligibility criteria refines treatment matching, providing more clinically relevant options based on a patient's complete history.
GenomOncology offers seamless integration with existing systems through its GO API Suite, enabling bidirectional data flow with any LIS, EHR (e.g., Epic, Meditech, Cerner), or LIMS, on any infrastructure, using standards-based HL7, FHIR, and REST connectivity. The platform supports both cloud-ready and on-premise deployment options, offering flexibility and data sovereignty. They also partner with other genomic intelligence companies like Genomenon to enhance germline variant classification and genomic reporting.
What the Web Says
GenomOncology is a healthcare technology company focused on precision medicine for cancer, offering a suite of solutions to transform genomic data into actionable insights for clinicians and researchers. Their products aim to streamline genomic reporting, standardize variant interpretation, and improve clinical trial matching. While their mission and product capabilities are generally viewed positively, the company appears to struggle with employee retention and establishing a consistent company culture.
Overall: MixedStrengths
- Comprehensive, end-to-end solution for precision oncology from analysis to decision support.
- Deep integration capabilities with existing EHR, LIMS, and in-house systems.
- Automates complex variant interpretation following major guidelines (AMP/ASCO/CAP, ACMG).
- Highly configurable and customizable to fit unique institutional workflows and data environments.
- Includes both proprietary and licensed content for up-to-date knowledge base.
- Improved efficiency and turnaround time for data analysis and reporting of variants.
Limitations
- Pricing is not transparent and likely high-cost due to enterprise focus.
- Steep learning curve for non-specialized users due to the complexity of the domain and features.
- Requires significant implementation and integration effort to connect to existing hospital/lab infrastructure.
- Limited public reviews available to assess user satisfaction and support quality.
- Struggles to retain talent, possibly due to a lack of established culture and team structure balance.
- Certain employees/roles are appreciated more than others.
Based on reviews from: Zippia, Indeed.com, IntuitionLabs.ai, explainx.ai, Reddit, Precision Oncology Solutions, Labcorp
Last updated: 2026-08-23
Videos
News, demos, and interviews about GenomOncology.
Videos load interactively. If none appear, search YouTube for GenomOncology →
Press & Coverage
Frequently Asked Questions
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]